The decision to have President Trump fly part of the way home on an old Air Force One instead of his newly refurbished and gifted plane from Qatar is raising questions about just how secure the new ...

Attorneys at a key hearing for the man accused of assassinating Charlie Kirk sparred over whether a police interview should be made public, with Kirk’s family attorney saying that sealing it will only ...

Interactive Go Interview Platform - 30+ coding challenges with instant feedback, AI interview simulation, competitive leaderboards, and automated testing. From beginner to advanced levels with ...

Earlier this week, Chris Pronger mentioned on OverDrive that he spoke with MLSE during their search for a president of hockey operations role. He said the conversation with Keith Pelley went well, ...

Cincinnati area defense attorneys are raising concerns about the credibility of a former Miami Valley Crime Lab analyst accused of altering test results.Bill Gallagher is representing the owners of ...

A powerful blast near the Jerusalem-area city of Beit Shemesh on Saturday night has triggered widespread speculation after dramatic visuals from the site spread rapidly across social media. The ...

Robert Davis is an award-winning journalist and senior editor at RawStory. Before joining the team, he wrote for publications such as Forbes, Business Insider, Capital & Main, and The Colorado Sun, to ...

Taiwan has pushed back against a growing number of foreign governments that label it part of China in their internal systems. But questions are mounting over whether Taipei’s retaliatory moves can ...

As Alberta attempts to be Canada’s top destination for data centres, some of these power-hungry facilities could lead to an upward jolt in electricity prices, analysts say. The group that oversees the ...

The conservative commentator accused US Ambassador to Israel Mike Huckabee of 'working for Israel' during a recent interview at the Ben-Gurion Airport. In a two-and-a-half-hour episode released Friday ...

FDA vouchers are normally a coveted prize for biopharma companies, but a surprise rejection for Disc Medicine’s rare disease drug has biopharma reconsidering. The FDA’s rejection of Disc Medicine’s ...